New Method for Delivering Drugs to Lung Metastases: Algae-Based Biohybrid Microrobots

Updated on: June 21,2024

New Method for Delivering Drugs to Lung Metastases: Algae-Based Biohybrid Microrobots

Updated on:June 21,2024

Lung cancer screening dramatically increases long-term survival rate

byRadiological Society of North AmericaAxial CT images of pulmonary nodules. (A) Malignant nodule. (B) Benign nodule. Credit: Radiological Society of North AmericaDiagnosing early-stage lung can

Updated on: December 22,2023

Lung cancer screening dramatically increases long-term survival rate

byRadiological Society of North AmericaAxial CT images of pulmonary nodules. (A) Malignant nodule. (B) Benign nodule. Credit: Radiological Society of North AmericaDiagnosing early-stage lung can

Updated on:December 22,2023

Innovative technology shows great promise against certain head and neck cancers

by Rachel Sauer,CU Anschutz Medical CampusCredit: Pixabay/CC0 Public DomainOver the past decade, human papillomavirus (HPV) has increasingly been identified as a significant cause of certain hea

Updated on: December 19,2023

Innovative technology shows great promise against certain head and neck cancers

by Rachel Sauer,CU Anschutz Medical CampusCredit: Pixabay/CC0 Public DomainOver the past decade, human papillomavirus (HPV) has increasingly been identified as a significant cause of certain hea

Updated on:December 19,2023

CARM1 drives triple-negative breast cancer progression by coordinating with HIF1A: Study

by Higher Education PressCoactivator-associated arginine methyltransferase 1 (CARM1) was recruited by hypoxia-inducible factor 1 subunit alpha (HIF1A) to form a complex and transactivate CDK4 and HIF1

Updated on: July 09,2024

CARM1 drives triple-negative breast cancer progression by coordinating with HIF1A: Study

by Higher Education PressCoactivator-associated arginine methyltransferase 1 (CARM1) was recruited by hypoxia-inducible factor 1 subunit alpha (HIF1A) to form a complex and transactivate CDK4 and HIF1

Updated on:July 09,2024

A case for routine evaluation of HER2 expression in ductal carcinoma in situ

by Impact JournalsCredit: Unsplash/CC0 Public DomainA new editorial paper was published inOncoscienceand is titled "HER2 expression should be routinely evaluated in DCIS to avoid unde

Updated on: December 20,2023

A case for routine evaluation of HER2 expression in ductal carcinoma in situ

by Impact JournalsCredit: Unsplash/CC0 Public DomainA new editorial paper was published inOncoscienceand is titled "HER2 expression should be routinely evaluated in DCIS to avoid unde

Updated on:December 20,2023

AI-Assisted Histopathology: Refining the Distinction Between Sebaceous and Squamous Cell Carcinoma of the Eyelid

Updated on: August 30,2025

AI-Assisted Histopathology: Refining the Distinction Between Sebaceous and Squamous Cell Carcinoma of the Eyelid

Updated on:August 30,2025

Protein identified as a potential biomarker and therapeutic target for aggressive neuroendocrine carcinomas

JANUARY 29, 2024 Editors' notesby Denise Heady,University of California, Los AngelesCredit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2023.101381Investigators from the UCLA

Updated on: March 14,2024

Protein identified as a potential biomarker and therapeutic target for aggressive neuroendocrine carcinomas

JANUARY 29, 2024 Editors' notesby Denise Heady,University of California, Los AngelesCredit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2023.101381Investigators from the UCLA

Updated on:March 14,2024

Study shows lactate may prompt cancer formation

byCU Anschutz Medical CampusCancer cell during cell division. Credit: National Institutes of HealthA byproduct of glucose called lactate, used by every cell in the body, may also prompt a mutate

Updated on: December 22,2023

Study shows lactate may prompt cancer formation

byCU Anschutz Medical CampusCancer cell during cell division. Credit: National Institutes of HealthA byproduct of glucose called lactate, used by every cell in the body, may also prompt a mutate

Updated on:December 22,2023

Research raises hope for new therapies for chordoma, a rare bone cancer

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsChordoma is literally a one in a million cancer, with few effective treatment options. A new unde

Updated on: May 31,2024

Research raises hope for new therapies for chordoma, a rare bone cancer

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsChordoma is literally a one in a million cancer, with few effective treatment options. A new unde

Updated on:May 31,2024

Standard pathology tests outperform molecular subtyping in bladder cancer

byMedical College of Georgia at Augusta UniversityDr. Vinata B. Lokeshwar and graduate students Sarrah S. Lahorewala and Daley S. Morera. Credit: Phil Jones, Senior Photographer, Augusta Univers

Updated on: December 23,2023

Standard pathology tests outperform molecular subtyping in bladder cancer

byMedical College of Georgia at Augusta UniversityDr. Vinata B. Lokeshwar and graduate students Sarrah S. Lahorewala and Daley S. Morera. Credit: Phil Jones, Senior Photographer, Augusta Univers

Updated on:December 23,2023

Having dense breasts is linked to cancer, but advice about breast density can depend on where you live

Updated on: April 29,2025

Having dense breasts is linked to cancer, but advice about breast density can depend on where you live

Updated on:April 29,2025

FDA approves engineered cell therapy for treating rare sarcoma

by Julie Grisham,Memorial Sloan Kettering Cancer CenterCredit: CC0 Public DomainThe U.S. Food and Drug Administration (FDA) hasgranted accelerated approvalfor the immunotherapy afami

Updated on: August 27,2024

FDA approves engineered cell therapy for treating rare sarcoma

by Julie Grisham,Memorial Sloan Kettering Cancer CenterCredit: CC0 Public DomainThe U.S. Food and Drug Administration (FDA) hasgranted accelerated approvalfor the immunotherapy afami

Updated on:August 27,2024